Utama › Obesiti › California › Concord
Kajian klinikal Obesiti di Concord, CA
18 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Concord (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 2
- John Muir Health - Concord /ID# 282469, Concord
- Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi jauh
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Mengambil pesertaFasa 2
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi jauh
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
- Research Site, Walnut Creek · 5 mi jauh
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Mengambil pesertaFasa 3
- Research Site, Walnut Creek · 5 mi jauh
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Mengambil pesertaFasa 3
- Diablo Clinical Research, Walnut Creek · 5 mi jauh
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Mengambil pesertaFasa 3
- Diablo Clinical Research, Walnut Creek · 5 mi jauh
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- John Muir Physicians Network, Concord
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Mengambil pesertaFasa 2
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi jauh
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Mengambil pesertaFasa 3
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Mengambil pesertaFasa 1
- Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauh
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- San Antonio, TX40 kajian
- Washington, DC33 kajian
- Orlando, FL31 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD25 kajian
- Jacksonville, FL25 kajian
Kajian lain di Concord
- Berat Badan Berlebihan16 kajian
- Kanser Paru-paru Bukan Sel Kecil14 kajian
- Gangguan Depresi Major12 kajian
- Diabetes Jenis 210 kajian
- Kanser Paru-paru9 kajian
- Kanser Payudara9 kajian
- Migrain8 kajian
- Kanser (semua jenis)7 kajian
- Kanser Prostat6 kajian
- Depresi6 kajian
- Tekanan Darah Tinggi5 kajian
- Diabetes5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.